Occurrence of ecchymotic angioedema-like cutaneous lesions as a possible side effect of fingolimod

Saved in:
Bibliographic Details
Published in:Multiple sclerosis 2014-10, Vol.20 (12), p.1666-1667
Main Authors: Masera, S, Chiavazza, C, Mattioda, A, Superti, G, Beggiato, E, Crosasso, P, Broganelli, P, Pinessi, L, Cavalla, P
Format: Article
Language:English
Subjects:
Adult
Angioedema
Angioedema - chemically induced
Angioedema - diagnosis
Angioedema - pathology
Female
Fingolimod Hydrochloride
Humans
Immunosuppressive Agents - adverse effects
Knee - pathology
Multiple Sclerosis, Relapsing-Remitting - drug therapy
Multiple Sclerosis, Relapsing-Remitting - metabolism
Propylene Glycols - adverse effects
Receptors, Lysosphingolipid - antagonists & inhibitors
Receptors, Lysosphingolipid - metabolism
Skin - pathology
Sphingosine - adverse effects
Sphingosine - analogs & derivatives
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c332t-bd2ce4166f40680186b5e9417e31353060ed4e31f0f04484432d95a547c2a9033
cites cdi_FETCH-LOGICAL-c332t-bd2ce4166f40680186b5e9417e31353060ed4e31f0f04484432d95a547c2a9033
container_end_page 1667
container_issue 12
container_start_page 1666
container_title Multiple sclerosis
container_volume 20
creator Masera, S
Chiavazza, C
Mattioda, A
Superti, G
Beggiato, E
Crosasso, P
Broganelli, P
Pinessi, L
Cavalla, P
description
doi_str_mv 10.1177/1352458514525872
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1617087375</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1352458514525872</sage_id><sourcerecordid>3472816691</sourcerecordid><originalsourceid>FETCH-LOGICAL-c332t-bd2ce4166f40680186b5e9417e31353060ed4e31f0f04484432d95a547c2a9033</originalsourceid><addsrcrecordid>eNp1UE1Lw0AQXUSxtXr3JAueo7Nf2fQoxS8QetFz2Gxm69YkW7PJof_eLa0igjAwD-a9NzOPkEsGN4xpfcuE4lIViknFVaH5EZkyqXUGcw3HCadxtptPyFmMawDQWqhTMuEyB1EUYkqqpbVj32NnkQZH0dr3bRsGb6npVj5gja3JGv-B1I6D6TCMkTYYfegiNanoJsToqwZp9DVSdA7tsHNyvluFxrehPicnzjQRLw59Rt4e7l8XT9nL8vF5cfeSWSH4kFU1tyhZnjsJeQGsyCuFc8k0ivSHgBywlgk7cCBlIaXg9VwZJbXlZg5CzMj13nfTh88R41Cuw9h3aWXJcqah0EKrxII9y_bp8h5duel9a_ptyaDchVr-DTVJrg7GY9Vi_SP4TjERsj0hmhX-2vqf4RcOqn2V</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1617087375</pqid></control><display><type>article</type><title>Occurrence of ecchymotic angioedema-like cutaneous lesions as a possible side effect of fingolimod</title><source>SAGE</source><creator>Masera, S ; Chiavazza, C ; Mattioda, A ; Superti, G ; Beggiato, E ; Crosasso, P ; Broganelli, P ; Pinessi, L ; Cavalla, P</creator><creatorcontrib>Masera, S ; Chiavazza, C ; Mattioda, A ; Superti, G ; Beggiato, E ; Crosasso, P ; Broganelli, P ; Pinessi, L ; Cavalla, P</creatorcontrib><identifier>ISSN: 1352-4585</identifier><identifier>EISSN: 1477-0970</identifier><identifier>DOI: 10.1177/1352458514525872</identifier><identifier>PMID: 24603883</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Adult ; Angioedema ; Angioedema - chemically induced ; Angioedema - diagnosis ; Angioedema - pathology ; Female ; Fingolimod Hydrochloride ; Humans ; Immunosuppressive Agents - adverse effects ; Knee - pathology ; Multiple Sclerosis, Relapsing-Remitting - drug therapy ; Multiple Sclerosis, Relapsing-Remitting - metabolism ; Propylene Glycols - adverse effects ; Receptors, Lysosphingolipid - antagonists &amp; inhibitors ; Receptors, Lysosphingolipid - metabolism ; Skin - pathology ; Sphingosine - adverse effects ; Sphingosine - analogs &amp; derivatives</subject><ispartof>Multiple sclerosis, 2014-10, Vol.20 (12), p.1666-1667</ispartof><rights>The Author(s) 2014</rights><rights>SAGE Publications © Oct 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c332t-bd2ce4166f40680186b5e9417e31353060ed4e31f0f04484432d95a547c2a9033</citedby><cites>FETCH-LOGICAL-c332t-bd2ce4166f40680186b5e9417e31353060ed4e31f0f04484432d95a547c2a9033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906,79113</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24603883$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Masera, S</creatorcontrib><creatorcontrib>Chiavazza, C</creatorcontrib><creatorcontrib>Mattioda, A</creatorcontrib><creatorcontrib>Superti, G</creatorcontrib><creatorcontrib>Beggiato, E</creatorcontrib><creatorcontrib>Crosasso, P</creatorcontrib><creatorcontrib>Broganelli, P</creatorcontrib><creatorcontrib>Pinessi, L</creatorcontrib><creatorcontrib>Cavalla, P</creatorcontrib><title>Occurrence of ecchymotic angioedema-like cutaneous lesions as a possible side effect of fingolimod</title><title>Multiple sclerosis</title><addtitle>Mult Scler</addtitle><subject>Adult</subject><subject>Angioedema</subject><subject>Angioedema - chemically induced</subject><subject>Angioedema - diagnosis</subject><subject>Angioedema - pathology</subject><subject>Female</subject><subject>Fingolimod Hydrochloride</subject><subject>Humans</subject><subject>Immunosuppressive Agents - adverse effects</subject><subject>Knee - pathology</subject><subject>Multiple Sclerosis, Relapsing-Remitting - drug therapy</subject><subject>Multiple Sclerosis, Relapsing-Remitting - metabolism</subject><subject>Propylene Glycols - adverse effects</subject><subject>Receptors, Lysosphingolipid - antagonists &amp; inhibitors</subject><subject>Receptors, Lysosphingolipid - metabolism</subject><subject>Skin - pathology</subject><subject>Sphingosine - adverse effects</subject><subject>Sphingosine - analogs &amp; derivatives</subject><issn>1352-4585</issn><issn>1477-0970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp1UE1Lw0AQXUSxtXr3JAueo7Nf2fQoxS8QetFz2Gxm69YkW7PJof_eLa0igjAwD-a9NzOPkEsGN4xpfcuE4lIViknFVaH5EZkyqXUGcw3HCadxtptPyFmMawDQWqhTMuEyB1EUYkqqpbVj32NnkQZH0dr3bRsGb6npVj5gja3JGv-B1I6D6TCMkTYYfegiNanoJsToqwZp9DVSdA7tsHNyvluFxrehPicnzjQRLw59Rt4e7l8XT9nL8vF5cfeSWSH4kFU1tyhZnjsJeQGsyCuFc8k0ivSHgBywlgk7cCBlIaXg9VwZJbXlZg5CzMj13nfTh88R41Cuw9h3aWXJcqah0EKrxII9y_bp8h5duel9a_ptyaDchVr-DTVJrg7GY9Vi_SP4TjERsj0hmhX-2vqf4RcOqn2V</recordid><startdate>20141001</startdate><enddate>20141001</enddate><creator>Masera, S</creator><creator>Chiavazza, C</creator><creator>Mattioda, A</creator><creator>Superti, G</creator><creator>Beggiato, E</creator><creator>Crosasso, P</creator><creator>Broganelli, P</creator><creator>Pinessi, L</creator><creator>Cavalla, P</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20141001</creationdate><title>Occurrence of ecchymotic angioedema-like cutaneous lesions as a possible side effect of fingolimod</title><author>Masera, S ; Chiavazza, C ; Mattioda, A ; Superti, G ; Beggiato, E ; Crosasso, P ; Broganelli, P ; Pinessi, L ; Cavalla, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c332t-bd2ce4166f40680186b5e9417e31353060ed4e31f0f04484432d95a547c2a9033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Angioedema</topic><topic>Angioedema - chemically induced</topic><topic>Angioedema - diagnosis</topic><topic>Angioedema - pathology</topic><topic>Female</topic><topic>Fingolimod Hydrochloride</topic><topic>Humans</topic><topic>Immunosuppressive Agents - adverse effects</topic><topic>Knee - pathology</topic><topic>Multiple Sclerosis, Relapsing-Remitting - drug therapy</topic><topic>Multiple Sclerosis, Relapsing-Remitting - metabolism</topic><topic>Propylene Glycols - adverse effects</topic><topic>Receptors, Lysosphingolipid - antagonists &amp; inhibitors</topic><topic>Receptors, Lysosphingolipid - metabolism</topic><topic>Skin - pathology</topic><topic>Sphingosine - adverse effects</topic><topic>Sphingosine - analogs &amp; derivatives</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Masera, S</creatorcontrib><creatorcontrib>Chiavazza, C</creatorcontrib><creatorcontrib>Mattioda, A</creatorcontrib><creatorcontrib>Superti, G</creatorcontrib><creatorcontrib>Beggiato, E</creatorcontrib><creatorcontrib>Crosasso, P</creatorcontrib><creatorcontrib>Broganelli, P</creatorcontrib><creatorcontrib>Pinessi, L</creatorcontrib><creatorcontrib>Cavalla, P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Multiple sclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Masera, S</au><au>Chiavazza, C</au><au>Mattioda, A</au><au>Superti, G</au><au>Beggiato, E</au><au>Crosasso, P</au><au>Broganelli, P</au><au>Pinessi, L</au><au>Cavalla, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Occurrence of ecchymotic angioedema-like cutaneous lesions as a possible side effect of fingolimod</atitle><jtitle>Multiple sclerosis</jtitle><addtitle>Mult Scler</addtitle><date>2014-10-01</date><risdate>2014</risdate><volume>20</volume><issue>12</issue><spage>1666</spage><epage>1667</epage><pages>1666-1667</pages><issn>1352-4585</issn><eissn>1477-0970</eissn><cop>London, England</cop><pub>SAGE Publications</pub><pmid>24603883</pmid><doi>10.1177/1352458514525872</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1352-4585
ispartof Multiple sclerosis, 2014-10, Vol.20 (12), p.1666-1667
issn 1352-4585
1477-0970
language eng
recordid cdi_proquest_journals_1617087375
source SAGE
subjects Adult
Angioedema
Angioedema - chemically induced
Angioedema - diagnosis
Angioedema - pathology
Female
Fingolimod Hydrochloride
Humans
Immunosuppressive Agents - adverse effects
Knee - pathology
Multiple Sclerosis, Relapsing-Remitting - drug therapy
Multiple Sclerosis, Relapsing-Remitting - metabolism
Propylene Glycols - adverse effects
Receptors, Lysosphingolipid - antagonists & inhibitors
Receptors, Lysosphingolipid - metabolism
Skin - pathology
Sphingosine - adverse effects
Sphingosine - analogs & derivatives
title Occurrence of ecchymotic angioedema-like cutaneous lesions as a possible side effect of fingolimod
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T16%3A42%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Occurrence%20of%20ecchymotic%20angioedema-like%20cutaneous%20lesions%20as%20a%20possible%20side%20effect%20of%20fingolimod&rft.jtitle=Multiple%20sclerosis&rft.au=Masera,%20S&rft.date=2014-10-01&rft.volume=20&rft.issue=12&rft.spage=1666&rft.epage=1667&rft.pages=1666-1667&rft.issn=1352-4585&rft.eissn=1477-0970&rft_id=info:doi/10.1177/1352458514525872&rft_dat=%3Cproquest_cross%3E3472816691%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c332t-bd2ce4166f40680186b5e9417e31353060ed4e31f0f04484432d95a547c2a9033%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1617087375&rft_id=info:pmid/24603883&rft_sage_id=10.1177_1352458514525872&rfr_iscdi=true